As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...

The FDA had proposed removing phenylephrine, a widely used ingredient to treat nasal congestion, from over-the-counter cold ...

(WXYZ) — The Food and Drug Administration has updated labels for popular weight loss drugs like Ozempic and Wegovy. A new ...

The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients ...

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

The FDA has granted LBL-034 orphan drug designation for relapsed/refractory multiple myeloma treatment. LBL-034 has received ...

And the labeling for the drugs notes they ... there may be a positive benefit/risk with the drug in patients with an eGFR ≥60 ...

As an alternative, some doctors have been prescribing metformin—an oral diabetes drug—off-label for weight loss ... says ...

“We are pleased to have been granted Orphan Drug designation by the US FDA for AT-02 in ATTR amyloidosis,” said Gregory Bell, MD, Chief Medical Officer at Attralus. “Current approved therapies for ...

Garner, MD, Medical Director at SimpleFixRx to review ... Medication produced by compounded pharmacies instead of the ...

Obe-cel is the first FDA-approved CAR T-cell therapy for B-ALL without a REMS ... offering an attractive risk benefit profile ...

FDA clearance of HG202 marks a significant milestone for CRISPR ... binding pathway through the Cas13 RNA editor to knockdown ...